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Over 14 million cancer cases were diagnosed worldwide in 2012 and cancer 
incidence is expected to increase in the coming years1,2. The rising numbers 
of cancer survivors in many countries makes the identification of new 
therapeutic options an increasingly pressing issue3. Tumor recurrence and 
metastasis is the most frequent cause of morbidity and mortality in cancer 
patients and thus needs to be a focus for new therapeutic developments.  A 
central issue in the treatment of metastatic cancers is that these tumors gain 
resistance to chemotherapeutic and targeted biological agents4-6. Despite the 
healthcare and economic burdens associated with cancer recurrence, many 
aspects of the basic biology and physiology of tumor metastasis remain poorly 
understood. Many open questions remain about the triggers or pre-
dispositions that lead to early invasion of cancer cells away from the primary 
tumor, or that then favor intravasation or long-term survival of tumor cells in 
secondary organs.  
 
This series of AJP-Cell Physiology Reviews highlights recent research that is 
yielding insights into the early events that can promote metastatic disease.  
Metastasis initiation is considered to involve cancer stem-like cells with long 
term self renewal capability, that are often under high selection pressure and 
may exhibit the ability to transition between migratory and proliferative states7. 
It is increasingly recognised that the local microenvironment, including 
extracellular matrix and normal cell types of the tumor-adjacent stroma, has 
an important role in determining cancer cell behaviors. In addition, evidence 
for pre-conditioning of metastatic niches by secreted or exosomal products of 
the cancer cells themselves has highlighted the complexity of the dialogue 
that occurs between cancer and stromal cells7,8.  
 
Much of the research in these areas relates to breast or colon carcinomas, 
that are amongst the most common forms of cancer worldwide. However, 
there are rarer cancers with very poor survival rates. A prime example is 
ovarian cancer, in which the mechanisms that drive dissemination within the 
peritoneal cavity appear to be very different from those that underlie tumor 
invasion within a solid tissue. We open this series with a Review by Samuel 
Mok (M.D. Anderson Cancer Center) and colleagues on the current 
knowledge of cellular and molecular mechanisms of ovarian cancer 
metastasis9. The issue also features a Review by Rajender Motiani (CSIR-
Institute of Genomics and Integrative Biology) and colleagues on the 
dysregulation of STIM and Orai proteins in many cancers and the possibility of 
targeting these proteins as a form of cancer therapy10. Future Reviews in this 
Theme will include articles that provide perspectives on the nature of tumor-
initiating cells, mechanisms that enable cancer cells to enter the blood 
circulation, and the molecular basis of communications between tumor cells 
and the extracellular matrix and microenvironment in distant organs.  
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